Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997

B N Manktelow1, E S Draper, S Annamalai

  • 1Department of Epidemiology and Public Health, Leicester University Medical School, 22-28 Princess Road West, Leicester LE1 6TP, UK.

Insights

The incidence of chronic lung disease of prematurity increased significantly between 1987 and 1992, but stabilized between 1992 and 1997, despite improved survival rates for premature infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Public Health

Background:

  • The incidence of chronic lung disease of prematurity (CLD) has been a significant concern in neonatal intensive care.
  • Changes in neonatal care practices may influence CLD rates and survival outcomes for extremely preterm infants.

Purpose of the Study:

  • To investigate temporal trends in the incidence of CLD among very preterm infants.
  • To assess changes in survival rates for this population over three distinct time periods.

Main Methods:

  • An observational study analyzing data from the Trent Health Region, UK, across three periods: 1987, 1992, and 1997.
  • Infants born at or before 32 weeks gestation and admitted to neonatal units were included.
  • CLD was defined by respiratory support or oxygen dependence at 28 days or 36 weeks corrected age.

Main Results:

  • Between 1987 and 1992, there was an increased admission of preterm infants, with a significant rise in CLD incidence despite improved survival after adjusting for gestational age and birth weight.
  • From 1992 to 1997, survival rates continued to improve significantly without a corresponding increase in CLD rates.
  • Adjusted analysis showed CLD incidence increased (OR 2.20-3.04) from 1987-1992, but stabilized (OR 0.72-0.88) from 1992-1997.

Conclusions:

  • Widening access to neonatal intensive care for the most immature infants has contributed to current high CLD rates.
  • Recent advancements in neonatal care have enhanced survival for preterm infants without exacerbating CLD risk.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: